XML 15 R5.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Cash Flows - USD ($)
6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Cash flows from operating activities:    
Net income (loss) $ 1,368,152 $ (2,005,734)
Discontinued operations 994,217 1,556,895
Net income (loss) from continuing operations 373,935 (3,562,629)
Adjustments to reconcile net income (loss) from continuing operations to net cash provided by (used in) operating activities:    
Depreciation and amortization expense 2,455,576 2,334,669
Share-based compensation 354,914 542,923
Decrease in non-cash contingent consideration (180,110) (645,571)
Increase (Decrease) In Cash Surrender Value Of Life Insurance Policy (226,897) 215,116
Noncash interest expense 27,666 22,973
Gain on forgiveness of debt (2,187,140) 0
Net changes in assets and liabilities affecting operating activities:    
Accounts receivable 3,230,220 (80,421)
Inventories 2,309,914 1,158,916
Other current assets and other assets 866,987 802,534
Accounts payable and other current liabilities (3,008,323) 2,413,768
Other long-term liabilities (526,189) (869,644)
Net cash provided by (used in) operating activities from continuing operations 3,490,553 2,332,634
Discontinued operations 994,217 1,371,437
Net cash provided by operating activities 4,484,770 3,704,071
Cash flows from investing activities:    
Additions to property and equipment (34,531) (50,883)
Note receivable investment funding (200,000) 0
Additions to intangible assets (132,323) (722,131)
Net cash used in investing activities (366,854) (773,014)
Cash flows from financing activities:    
Borrowings on line of credit 29,000,000 35,500,000
Repayments on line of credit (30,000,000) (37,000,000)
Cash payment of contingent consideration (1,423,586) (260,735)
Repurchase of subsidiary shares from noncontrolling interest 0 (800,000)
Repurchase of common shares (777,664) (1,209,220)
Net cash used in financing activities (3,201,250) (3,769,955)
Net increase (decrease) in cash and cash equivalents 916,666 (838,898)
Cash and cash equivalents at beginning of period 24,753,796 28,212,635
Cash and cash equivalents at end of period $ 25,670,462 $ 27,373,737